Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Aug;18(3):e264-e277.
doi: 10.18295/squmj.2018.18.03.002. Epub 2018 Dec 19.

Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review

Affiliations
Review

Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review

Roberto Berebichez-Fridman et al. Sultan Qaboos Univ Med J. 2018 Aug.

Abstract

First discovered by Friedenstein in 1976, mesenchymal stem cells (MSCs) are adult stem cells found throughout the body that share a fixed set of characteristics. Discovered initially in the bone marrow, this cell source is considered the gold standard for clinical research, although various other sources-including adipose tissue, dental pulp, mobilised peripheral blood and birth-derived tissues-have since been identified. Although similar, MSCs derived from different sources possess distinct characteristics, advantages and disadvantages, including their differentiation potential and proliferation capacity, which influence their applicability. Hence, they may be used for specific clinical applications in the fields of regenerative medicine and tissue engineering. This review article summarises current knowledge regarding the various sources, characteristics and therapeutic applications of MSCs.

Keywords: Adult Stem Cells; Cell Differentiation; Mesenchymal Stem Cells; Regenerative Medicine; Tissue Engineering.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Choo A, Ngo AS, Ding V, Oh S, Kiang LS. Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions. Methods Cell Biol. 2008;86:15–28. doi: 10.1016/S0091-679X(08)00002-2. - DOI - PubMed
    1. Hiew VV, Simat SFB, Teoh PL. The advancement of biomaterials in regulating stem cell fate. Stem Cell Rev. 2018;14:43–57. doi: 10.1007/s12015-017-9764-y. - DOI - PubMed
    1. Lv FJ, Tuan RS, Cheung KM, Leung VY. Concise review: The surface markers and identity of human mesenchymal stem cells. Stem Cells. 2014;32:1408–19. doi: 10.1002/stem.1681. - DOI - PubMed
    1. Wei X, Yang X, Han ZP, Qu FF, Shao L, Shi YF. Mesenchymal stem cells: A new trend for cell therapy. Acta Pharmacol Sin. 2013;34:747–54. doi: 10.1038/aps.2013.50. - DOI - PMC - PubMed
    1. Liras A. Future research and therapeutic applications of human stem cells: General, regulatory, and bioethical aspects. J Transl Med. 2010;8:131. doi: 10.1186/1479-5876-8-131. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources